High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma

Published:2015-06-22 Issue:10 Volume:50 Page:1375-1378
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Hong C R,Kang H J,Kim M S,Ju H Y,Lee J W,Kim H,Kim H-S,Park S-H,Park K D,Park J D,Shin H Y,Ahn H S

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2015145.pdf

Reference14 articles.

1. Ottaviani G, Jaffe N . The epidemiology of osteosarcoma. Cancer Treat Res 2009; 152: 3–13.

2. Ta HT, Dass CR, Choong PF, Dunstan DE . Osteosarcoma treatment: state of the art. Cancer Metastasis Rev 2009; 28: 247–263.

3. Lee JW, Kim H, Kang HJ, Kim HS, Park SH, Kim IO et al. Clinical characteristics and treatment results of pediatric osteosarcoma: the role of high dose chemotherapy with autologous stem cell transplantation. Cancer Res Treat 2008; 40: 172–177.

4. Whelan J, Seddon B, Perisoglou M . Management of osteosarcoma. Curr Treat Options Oncol 2006; 7: 444–455.

5. Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003; 21: 2011–2018.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcoma;Pediatric Blood & Cancer;2023-02-07

2. Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment;Journal of Natural Products;2022-09-19

3. Favorable outcome of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with nonmetastatic osteosarcoma and low-degree necrosis;Frontiers in Oncology;2022-09-13

4. High-dose melphalan-based chemotherapy and autologous stem-cell transplantation for high-risk osteosarcoma in children: A single-institute experience and review of the literature;Pediatric Hematology Oncology Journal;2021-12

5. Systematic Review of Recurrent Osteosarcoma Systemic Therapy;Cancers;2021-04-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3